Sintetica establishes US entity

MENDRISIO, Switzerland, Oct. 14, 2022 /CNW/ — Sintetica, a Swiss pharmaceutical company headquartered in Mendrisio specializing in injectables in the sector of pain therapy, has taken one other vital and significant step in its 100-year growth strategy.

On July 14, 2022 Sintetica established its subsidiary Sintetica US, headquartered in Princeton, Latest Jersey, headed by leading pharma expert Frank Mullery (President-Sintetica US). Frank Mullery brings with him greater than 20 years of outstanding experience within the pharmaceutical industry including as President of Mylan Institutional, President & Chief Industrial Officer of STI Pharma, and in key roles at Teva Pharmaceuticals, and Viropharma Inc. He established Mylan Institutional as a key player within the US injectable market successfully launching recent products and establishing strong relationships with key customers.

Nicola Caronzolo, Corporate CEO of Sintetica states: “I’m very happy with this further vital step in the expansion of our company, which is increasingly establishing itself on international markets through the standard of its products and the reliability of its services. With the establishment of our US subsidiary we are going to find a way to focus equally on B2B in addition to B2C markets within the US. Frank shall be instrumental in organising the B2C business of Sintetica within the US by working closely with GPO’s, IDN’s, hospitals, and other key stakeholders. Sintetica will even proceed to service its B2B partners within the US through its existing agreements. I would love to take this chance to thank the numerous people involved (employees, stakeholders and KOLs) who make our ongoing success story possible every single day“.

Frank Mullery, President of Sintetica US affirms: “I’m honored to have the chance to steer the Sintetica US team. It’s a really exciting time for our company. Sintetica is uniquely positioned with a powerful core business, best in school research and development, top quality Swiss manufacturing, and a helpful pipeline. I sit up for working with Nicola, our board, the management team and all Sintetica employees to proceed to grow the business and produce modern products to the US customers and patients”.

CONTACT: Daniele Fontana, Sustainability & HR Corporate Director, +41 79 218 90 57

Logo –

SOURCE Sintetica


Please enter your comment!
Please enter your name here